[go: up one dir, main page]

KR20220099259A - Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract - Google Patents

Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract Download PDF

Info

Publication number
KR20220099259A
KR20220099259A KR1020210001283A KR20210001283A KR20220099259A KR 20220099259 A KR20220099259 A KR 20220099259A KR 1020210001283 A KR1020210001283 A KR 1020210001283A KR 20210001283 A KR20210001283 A KR 20210001283A KR 20220099259 A KR20220099259 A KR 20220099259A
Authority
KR
South Korea
Prior art keywords
seed oil
safflower seed
mixture
skin whitening
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1020210001283A
Other languages
Korean (ko)
Other versions
KR102522196B1 (en
Inventor
김기호
명인정
김송희
김가현
김영수
Original Assignee
(주)기호바이오
충북대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)기호바이오, 충북대학교 산학협력단 filed Critical (주)기호바이오
Priority to KR1020210001283A priority Critical patent/KR102522196B1/en
Publication of KR20220099259A publication Critical patent/KR20220099259A/en
Application granted granted Critical
Publication of KR102522196B1 publication Critical patent/KR102522196B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic composition containing, as an active ingredient, a mixture obtained by mixing a hydrolysate of Carthamus tinctorius L. seed oil and an extract of Saururus chinensis (Lour.) Baill. in a specific weight part proportion. The cosmetic composition has a synergistic effect due to the complex action of two mechanisms, such as decreased levels of tyrosinase proteins and inhibition of tyrosinase production caused by the inhibition of microphthalmia-associated transcription factor (MITF) protein production due to decreased levels of MITF mRNA expression, thereby exhibiting an excellent skin whitening effect.

Description

홍화씨유 가수분해물과 삼백초 추출물의 혼합물을 유효성분으로 함유하는 피부미백용 조성물{Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract}Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract as active ingredients

본 발명은 홍화씨유 가수분해물과 삼백초 추출물의 혼합물을 유효성분으로 함유하는 피부미백용 조성물로서, 구체적으로 홍화씨유 가수분해물과 삼백초 추출물을 특정 중량부 비로 포함하여 피부미백 효과가 뛰어난 조성물에 관한 것이다.The present invention relates to a composition for skin whitening containing a mixture of safflower seed oil hydrolyzate and safflower seed extract as an active ingredient, and more particularly, to a composition having excellent skin whitening effect by including safflower seed oil hydrolyzate and safflower seed oil extract in a specific weight part ratio.

사람의 피부색은 크게 멜라닌의 양, 헤모글로빈, 카로틴 등에 의해 결정되며, 이 중 멜라닌이 가장 중요한 역할을 한다. 멜라닌(Melanin)은 피부 표피층에 존재하는 색소로서, 피부 표피층에 존재하는 멜라닌 세포에서 생성되며, 태양으로부터 오는 자외선을 막아 피부 손상을 방지하고, 피부 생체 내에 생겨난 유해산소 및 프리라디칼 등을 잡아주어 외부 유해인자들로부터 피부를 보호하는 역할을 수행한다. 그러나, 자외선에 지나치게 노출되거나 여러가지 환경적 요인에 의해 멜라닌이 과다하게 생성되는 경우 주근깨, 검버섯, 기미 등의 색소 침착과 피부 트러블을 일으키게 되는 문제가 있다.A person's skin color is largely determined by the amount of melanin, hemoglobin, and carotene, and melanin plays the most important role among them. Melanin is a pigment present in the epidermal layer of the skin, and is produced in melanocytes present in the epidermal layer of the skin. It plays a role in protecting the skin from harmful factors. However, when melanin is excessively generated by excessive exposure to ultraviolet rays or various environmental factors, there is a problem in that it causes pigmentation such as freckles, age spots, and blemishes and skin troubles.

멜라닌의 합성 과정을 구체적으로 살펴보면, 멜라노사이트(Melanocyte) 내의 멜라노좀(Melanosome)이라는 소포체에 존재하는 티로시나아제(Tyrosinase)라는 효소가 티로신(Tyrosine)을 기질로 하여 도파퀴논(DOPAauinone)을 생성하고, 도파퀴논이 자동 산화반응을 거쳐 도파크롬(DOPAchirome)이 된다. 다시 도파크롬은 효소 반응에 의해 멜라닌을 생성한다. 생성된 멜라닌은 멜라노좀을 통해 각질 세포로 옮겨지고, 여기에서 약 28일 간의 각화 과정을 거치면서 피부 표면으로 나와 각질과 함께 소실된다. Looking at the synthesis process of melanin in detail, an enzyme called tyrosinase present in the endoplasmic reticulum called melanosome in melanocytes uses tyrosine as a substrate to produce dopaquinone (DOPAauinone) and , dopaquinone undergoes an auto-oxidation reaction to become dopachrome (DOPAchirome). Again, dopachrome produces melanin by an enzymatic reaction. The generated melanin is transferred to keratinocytes through melanosomes, and from there, it is lost along with the dead skin cells through the keratinization process for about 28 days.

이 중, 티로시나아제는 멜라닌 합성의 초기 단계에서 멜라닌의 생성을 결정하는 효소로 Microphtalmia-asscociated transcription factor(MITF)라는 전사인자에 의해 발현된다. MITF는 티로시나아제 뿐만 아니라 멜라닌 형성에 필요한 TRP1과 TRP2의 효소 발현에도 관여하는 중요한 역할을 한다. 상기 효소들은 '멜라노솜(melanosome)'이라는 멜라닌 세포의 세포소기관에서 L-티로신을 유멜라닌 및 페오멜라닌 등 두 가지 유형의 멜라닌으로 전환할 수 있고, 합성된 멜라닌은 주위의 케라티노사이트(Keratinocyte)로 이동하여 피부색을 결정하거나 UV로부터 피부를 보호한다. Among them, tyrosinase is an enzyme that determines the production of melanin in the initial stage of melanin synthesis and is expressed by a transcription factor called Microphtalmia-associated transcription factor (MITF). MITF plays an important role in the expression of enzymes TRP1 and TRP2 required for melanin formation as well as tyrosinase. The enzymes can convert L-tyrosine into two types of melanin, such as eumelanin and pheomelanin, in the organelle of melanocytes called 'melanosome', and the synthesized melanin is produced by surrounding keratinocytes. to determine the skin color or protect the skin from UV rays.

종래에는 하이드로퀴논(hydroquinon)이나 아스콜빈산(ascorbic acid), 코지산(kojic acid), 글루타티온(glutathione)과 같은 티로시나아제에 대해 저해 활성을 가지는 물질을 연고, 에센스 등 화장료에 배합함으로써 피부미백 효과를 얻거나 기미, 주근깨 등의 피부 과색소 침착증을 개선하였다. Conventionally, a substance having inhibitory activity against tyrosinase, such as hydroquinon, ascorbic acid, kojic acid, and glutathione, is mixed with cosmetics such as ointments and essences to whiten the skin. The effect was obtained or the skin hyperpigmentation such as freckles and freckles was improved.

그러나, 하이드로퀴논은 소정의 미백 효과를 나타내나 피부 자극성이 심하여 배합량을 극소량으로 제한해야 하는 단점이 있고, 아스콜빈산은 산화되기 쉬워 이를 배합한 화장료는 변색, 변취되는 문제가 발생할 수 있다. 또한 글루타티온, 시스테인 등의 티올계 화합물은 특유의 불쾌한 냄새를 가질 뿐 아니라, 경피 흡수에도 문제가 있고, 이들의 배당체 및 유도체들도 극성이 높으므로 화장료 배합 성분으로 사용하기 어렵다. 한편, 태반 추출물 등은 피부 자극성은 없으나, 미백 효과가 부족한 문제가 있으며, 최근에는 광우병 유발의 위험성으로 인하여 그 사용이 금지된 바 있다. However, hydroquinone exhibits a predetermined whitening effect, but has severe skin irritation, so the blending amount must be limited to a very small amount. In addition, thiol-based compounds such as glutathione and cysteine not only have a characteristic unpleasant odor, but also have a problem in transdermal absorption, and their glycosides and derivatives are also highly polar, making it difficult to use as a cosmetic formulation ingredient. On the other hand, the placenta extract has no skin irritation, but has a problem of insufficient whitening effect, and has recently been banned due to the risk of inducing mad cow disease.

본 발명자들은, 종래 기술의 문제점을 해결하기 위해 안출한 것으로, 천연에서 얻은 홍화씨유 가수분해물과 삼백초 추출물을 특정 중량부 비로 혼합하여 얻은 혼합물을 유효성분으로 함유하는 경우, 티로시나아제(Tyrosinase) 단백질 레벨 억제 및 MITF-M 단백질 레벨을 억제하여 티로시나아제(Tyrosinase) 생성을 저해하는 등 2가지 기전의 복합적인 작용에 의한 상승 작용으로 뛰어난 피부미백 효과를 얻을 수 있다는 점을 실험을 통하여 확인하고 본 발명을 완성하게 되었다. The present inventors have devised to solve the problems of the prior art, and when it contains as an active ingredient a mixture obtained by mixing a hydrolyzate of safflower seed oil obtained from nature and an extract by weight in a specific weight part ratio, tyrosinase (Tyrosinase) protein It has been confirmed through experiments that an excellent skin whitening effect can be obtained through a synergistic action by a complex action of two mechanisms, such as inhibiting the level of MITF-M protein and inhibiting the production of tyrosinase. invention was completed.

이에, 본 발명은 홍화씨유 가수분해물 및 삼백초 추출물의 혼합물을 유효성분으로 함유하는, 피부미백용 화장료 조성물을 제공하는 것을 그 목적으로 한다. Accordingly, it is an object of the present invention to provide a cosmetic composition for skin whitening, which contains a mixture of safflower seed oil hydrolyzate and extract of ginseng oil as an active ingredient.

또한, 본 발명이 해결하고자 하는 기술적 과제는 이상에서 언급한 기술적 과제로 제한되지 않으며, 언급되지 않은 또 다른 기술적 과제들은 아래의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다. In addition, the technical problems to be solved by the present invention are not limited to the technical problems mentioned above, and other technical problems not mentioned are clearly to those of ordinary skill in the art to which the present invention belongs from the description below. can be understood

본 명세서에서는, 홍화씨유 가수분해물 및 삼백초 추출물의 혼합물을 유효성분으로 함유하는, 피부미백용 화장료 조성물을 제공한다. In the present specification, it provides a cosmetic composition for skin whitening, which contains a mixture of safflower seed oil hydrolyzate and extract of safflower oil as an active ingredient.

상기 혼합물은 홍화씨유 가수분해물 및 삼백초 추출물을 2 : 0.5 내지 1.5 중량부 비로 혼합한 것일 수 있다.The mixture may be a mixture of a hydrolyzate of safflower seed oil and an extract of safflower seed oil in a ratio of 2: 0.5 to 1.5 parts by weight.

상기 홍화씨유 가수분해물은 홍화씨유에 수산화나트륨(NaOH), 수산화칼슘(Ca(OH)2), 수산화리튬(LiOH) 및 수산화칼륨(KOH)으로 이루어진 군에서 선택되는 1종 이상의 알칼리금속 수산화물을 처리하여 가수분해시킨 것 또는, 홍화씨유에 에스테르 가수분해 효소를 첨가하여 가수분해시킨 것일 수 있다. The safflower seed oil hydrolyzate is hydrolyzed by treating safflower seed oil with at least one alkali metal hydroxide selected from the group consisting of sodium hydroxide (NaOH), calcium hydroxide (Ca(OH) 2 ), lithium hydroxide (LiOH) and potassium hydroxide (KOH). It may be decomposed or hydrolyzed by adding an ester hydrolase to safflower seed oil.

상기 삼백초 추출물은 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 부틸렌글리콜, 프로필렌글리콜, 함수부틸렌글리콜, 함수프로필렌글리콜 및 함수글리세린으로 이루어지는 군에서 선택되는 1종 이상의 용매로 추출된 것일 수 있다.The extract of trifolieae is one or more solvents selected from the group consisting of water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, hydrous butylene glycol, hydrous propylene glycol, and hydrous glycerin. may have been extracted.

상기 혼합물은 조성물 전체 중량 기준, 0.001 내지 50 중량%로 포함되는 것일 수 있다.The mixture may be included in an amount of 0.001 to 50% by weight based on the total weight of the composition.

상기 조성물은 유연화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 스프레이 및 파우더로 이루어진 군에서 선택된 1종 이상의 제형을 가지는 것일 수 있다. The composition may have one or more formulations selected from the group consisting of softening lotion, nourishing lotion, nourishing cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray and powder.

본 발명에 따라 제조된 피부미백용 화장료 조성물은 티로시나아제(Tyrosinase) 단백질 레벨 억제 및 MITF mRNA 발현 억제에 따른 MITF 단백질 생성 저해에 의한 티로시나아제(Tyrosinase) 생성 억제 등 2가지 기전의 복합적인 작용에 의한 상승 효과로서 뛰어난 피부미백 효과를 나타낸다. The cosmetic composition for skin whitening prepared according to the present invention has a complex action of two mechanisms, such as inhibition of tyrosinase protein level and inhibition of MITF protein production by inhibition of MITF mRNA expression. It shows excellent skin whitening effect as a synergistic effect by

도 1은 본 발명의 일실시예에 따라 제조된 홍화씨유 가수분해물의 리놀레산 함량을 측정한 결과이다.
도 2는 본 발명의 일실시예에 따라 제조된 홍화씨유 가수분해물 및 삼백초 추출물 혼합물의 가속실험에 따른 안정성 테스트를 수행한 결과를 나타낸 것이다.
도 3은 본 발명의 일실시예에 따라 제조된 홍화씨유 가수분해물 및 삼백초 추출물(30% 에탄올 추출물, 70% 에탄올 추출물)의 세포생존율 테스트 결과를 나타낸 것이다.
도 4는 본 발명의 일실시예에 대하여 UVB 조사에 의한 멜라닌 생합성 억제 효과를 측정한 결과를 나타낸 것이다.
도 5는 본 발명의 일실시예에 대하여 α-MSH 자극에 의한 멜라닌 생합성 억제 효과를 측정한 결과를 나타낸 것이다.
도 6은 본 발명의 일실시예에 대하여 Pam212 및 B16F0 co-culture 조건에서 UV 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 IC50 농도를 측정한 것이다.
도 7은 본 발명의 일실시예에 대하여 B16F0 세포주에서 α-MSH 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 IC50 농도를 측정한 것이다.
도 8은 본 발명의 일실시예 및 비교예에 따른 홍화씨유 가수분해물 및 삼백초 추출물 혼합물의 세포생존율 테스트 결과를 나타낸 것이다.
도 9는 본 발명의 일실시예 및 비교예에 따른 홍화씨유 가수분해물 및 삼백초 추출물 혼합물의 Pam212 및 B16F0 co-culture 조건에서 UV 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 영향을 측정한 결과이다.
도 10은 본 발명의 일실시예 및 비교예에 따른 홍화씨유 가수분해물 및 삼백초 추출물 혼합물의 B16F0 세포주에서 α-MSH 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 영향을 측정한 결과이다.
도 11은 본 발명의 일실시예에 따른 홍화씨유 가수분해물 및 삼백초 추출물 혼합물의 멜라닌 합성 마커 MITF-M의 단백질 레벨 억제 효과를 측정한 결과이다.
도 12는 본 발명의 일실시예에 따른 홍화씨유 가수분해물 및 삼백초 추출물 혼합물의 멜라닌 합성 마커 티로시나아제(Tyrosinase)의 mRNA 및 단백질 레벨 억제 효과를 측정한 결과이다.
도 13은 본 발명의 일실시예에 따른 홍화씨유 가수분해물 및 삼백초 추출물 혼합물의 작용 기전을 개략적으로 나타낸 것이다.
1 is a result of measuring the content of linoleic acid in a hydrolyzate of safflower seed oil prepared according to an embodiment of the present invention.
Figure 2 shows the results of performing a stability test according to the accelerated experiment of the hydrolyzate of safflower seed oil and the extract mixture of safflower seed oil prepared according to an embodiment of the present invention.
Figure 3 shows the cell viability test results of safflower seed oil hydrolyzate and extract (30% ethanol extract, 70% ethanol extract) prepared according to an embodiment of the present invention.
Figure 4 shows the results of measuring the melanin biosynthesis inhibitory effect by UVB irradiation with respect to an embodiment of the present invention.
Figure 5 shows the results of measuring the melanin biosynthesis inhibitory effect by α-MSH stimulation with respect to an embodiment of the present invention.
6 is a measurement of IC 50 concentration of a sample for melanin biosynthesis generated by UV stimulation in Pam212 and B16F0 co-culture conditions for an embodiment of the present invention.
7 is a measurement of the IC 50 concentration of the sample for melanin biosynthesis generated by α-MSH stimulation in the B16F0 cell line with respect to an embodiment of the present invention.
Figure 8 shows the cell viability test results of the hydrolyzate of safflower seed oil and the extract mixture of safflower seed oil according to an embodiment and a comparative example of the present invention.
Figure 9 is a result of measuring the effect of the sample on the melanin biosynthesis produced by UV stimulation in Pam212 and B16F0 co-culture conditions of a mixture of safflower seed oil hydrolyzate and trifolium extract according to an embodiment and a comparative example of the present invention.
10 is a result of measuring the effect of the sample on the melanin biosynthesis produced by α-MSH stimulation in the B16F0 cell line of a mixture of safflower seed oil hydrolyzate and Tribaekcho extract according to an embodiment and a comparative example of the present invention.
11 is a result of measuring the protein level inhibitory effect of the melanin synthesis marker MITF-M of the hydrolyzate of safflower seed oil and the extract of trifolieae according to an embodiment of the present invention.
Figure 12 is a result of measuring the mRNA and protein level inhibitory effect of the melanin synthesis marker tyrosinase (Tyrosinase) of the hydrolyzate of safflower seed oil and the extract mixture of safflower seed oil according to an embodiment of the present invention.
Figure 13 schematically shows the mechanism of action of a mixture of safflower seed oil hydrolyzate and safflower oil extract according to an embodiment of the present invention.

이하, 첨부된 도면을 참조하여 본 발명의 실시 예에 대하여 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 이하에서 개시되는 실시 예에 한정되지 않는다. 또한 도면에서 본 발명을 명확하게 개시하기 위해서 본 발명과 관계없는 부분은 생략하였으며, 도면에서 동일하거나 유사한 부호들은 동일하거나 유사한 구성요소들을 나타낸다.Hereinafter, with reference to the accompanying drawings, embodiments of the present invention will be described in detail so that those of ordinary skill in the art can easily implement them. However, the present invention may be implemented in various different forms and is not limited to the embodiments disclosed below. In addition, in order to clearly disclose the present invention in the drawings, parts irrelevant to the present invention are omitted, and the same or similar symbols in the drawings indicate the same or similar components.

구체적으로 본 발명의 일실시예에 따른, 피부미백용 화장료 조성물은 홍화씨유 가수분해물 및 삼백초 추출물의 혼합물을 유효성분으로 함유하는 것일 수 있다.Specifically, the cosmetic composition for skin whitening according to an embodiment of the present invention may contain a mixture of a hydrolyzate of safflower seed oil and an extract of safflower oil as an active ingredient.

홍화(Safflower, Carthamus tinctorious L.)는 국화과에 속하는 일년생 초목으로 원산지는 아프가니스탄의 산악 지대 또는 에티오피아이며 중국, 티벳 등지에서 재배된다. 홍화의 약용 부위로는 꽃과 씨가 있으며 혈소판 응고를 억제시키고 출혈시간을 지연시킬 뿐만 아니라 혈장 콜레스테롤과 중성지방을 저하시키는 작용도 한다.Safflower (Carthamus tinctorious L.) is an annual plant belonging to the Asteraceae family, and its origin is in the mountainous regions of Afghanistan or Ethiopia, and is cultivated in China and Tibet. The medicinal parts of safflower include flowers and seeds, which inhibit platelet coagulation and delay bleeding time, as well as lower plasma cholesterol and triglycerides.

홍화씨는 세로토닌, 리그난 및 플라보노이드와 같은 페놀 화합물을 함유하고 있어 강한 항산화, 항고지혈증 효과를 가지고 있으며 특히 에스트로겐 유사활성을 지니고 있는 피토에스트로겐 성분으로서 기존의 피토에스트로겐 화합물로 알려진 성분과 유사하게 뼈 형성을 촉진함으로써 갱년기 여성의 골다공증을 예방하고 골결손시 신생골을 형성시킬 수 있다. Safflower seeds contain phenolic compounds such as serotonin, lignans and flavonoids, which have strong antioxidant and anti-hyperlipidemic effects. By doing so, it is possible to prevent osteoporosis in menopausal women and to form new bone in case of bone loss.

특히, 홍화씨유에는 리놀레산(Linoleic acid)을 비롯한 다량의 불포화지방산과 토코페롤을 함유하고 있어 항산화, 항혈전 및 항고혈압성 신소재로서 이용되고 있으며 이를 위해 볶은 홍화씨를 착유하여 식용유로서 사용하고 있다. In particular, safflower seed oil contains a large amount of unsaturated fatty acids including linoleic acid and tocopherol, so it is used as a new material with antioxidant, antithrombotic and antihypertensive properties.

한편, 본 발명에서는 홍화씨유 가수분해물을 사용하며, 본 발명의 일실시예에 따른, 홍화시유 가수분해물은 홍화씨유에 수산화나트륨(NaOH), 수산화칼슘(Ca(OH)2), 수산화리튬(LiOH) 및 수산화칼륨(KOH)으로 이루어진 군에서 선택되는 1종 이상의 알칼리금속 수산화물을 처리하여 가수분해시킨 것 또는, 홍화씨유에 에스테르 가수분해 효소를 첨가하여 가수분해시킨 것일 수 있으며, 상기 에스테르 가수분해 효소는 리파아제(Lipase), 예를 들어 리포자임(lipozyme)류 또는 리포판(lipopna)류일 수 있다. Meanwhile, in the present invention, a hydrolyzate of safflower seed oil is used, and the hydrolyzate of safflower oil according to an embodiment of the present invention is sodium hydroxide (NaOH), calcium hydroxide (Ca(OH) 2 ), lithium hydroxide (LiOH) and It may be hydrolyzed by treatment with one or more alkali metal hydroxides selected from the group consisting of potassium hydroxide (KOH), or hydrolyzed by adding an ester hydrolase to safflower seed oil, and the ester hydrolase is lipase ( Lipase), for example, lipozyme or lipopna may be used.

일례로, 상기 홍화씨유 가수분해물은 홍화씨유를 수산화나트륨 수용액에 첨가하여 약 80 내지 100℃ 온도 조건 범위 내의 항온수조에서 교반하면서 약 50 내지 70 분간 가수분해 반응을 수행하여 얻은 것일 수 있다. For example, the hydrolyzate of safflower seed oil may be obtained by adding safflower seed oil to an aqueous sodium hydroxide solution and performing a hydrolysis reaction for about 50 to 70 minutes while stirring in a constant temperature water bath within a temperature range of about 80 to 100 ° C.

삼백초(三白草; Saururus chinensis Baill)는 삼백초과의 다년생 초본으로 한국, 중국, 일본 등지에 분포하는데, 습지나 바닷가에서 자생하는 식물이다. 전초에는 퀘르세틴(quercetin), 퀘르시트린(quercitrin), 이소퀘르시트린(isoquercitrin), 루틴(rutin) 및 수용성 타닌(tannin) 등의 정유를 함유하고 있는데, 특히 퀘르세틴(quercetin)은 과산화지질 형성 억제작용, 항균효과, 항돌연변이작용, 발암성 물질의 활성 감소, 암세포의 생육저해, 혈압강하, 모세혈관 강화작용을 하며, 퀘르시트린(quercitrin)은 항염증, 진통 및 항산화 효과 등이 있다고 알려져 있다. 또한, 삼백초는 각기, 황달, 임탁, 대하, 옹종, 수종, 적취, 급만성요도염, 전립선염, 방광염, 임질, 이질, 과중한 노동으로 인한 피로, 타박상으로 인한 후유증과 근육통, 골격 및 골수의 염증에 의한 통증을 치료하는 효과가 있는 것으로 알려져 있다.Saururus chinensis Baill (三白草; Saururus chinensis Baill ) is a perennial herb in the family Trifoliumaceae, distributed in Korea, China, and Japan, and is a plant that grows wild in wetlands and beaches. The forage contains essential oils such as quercetin, quercitrin, isoquercitrin, rutin, and water-soluble tannin. It has antibacterial, anti-mutagenic, and carcinogenic properties, inhibits the growth of cancer cells, lowers blood pressure, and strengthens capillaries, and quercitrin is known to have anti-inflammatory, analgesic and antioxidant effects. In addition, three hundred seconds are used for beriberi, jaundice, ointment, oyster mushroom, swelling, hydrocephalus, redness, acute and chronic urethritis, prostatitis, cystitis, gonorrhea, dysentery, aftereffects and muscle pain caused by bruises, and inflammation of the skeleton and bone marrow. It is known to be effective in treating pain caused by

한편, 본 발명의 일실시예에 따른 삼백초 추출물은 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 부틸렌글리콜, 프로필렌글리콜, 함수부틸렌글리콜, 함수프로필렌글리콜 및 함수글리세린으로 이루어지는 군에서 선택되는 1종 이상의 용매로 추출된 것일 수 있고, 상세하게는 상온에서 30% 에탄올 수용액 내지 70% 에탄올 수용액으로 일주일간 추출하여 얻은 것, 더욱 상세하게는 상온에서 30% 에탄올 수용액으로 일주일간 추출하여 얻은 것일 수 있다. On the other hand, the extract according to an embodiment of the present invention is composed of water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, hydrous butylene glycol, hydrous propylene glycol and hydrous glycerin. It may be extracted with one or more solvents selected from the group, specifically, obtained by extraction with 30% ethanol aqueous solution at room temperature to 70% ethanol aqueous solution for one week, and more specifically, one week with 30% ethanol aqueous solution at room temperature It may be obtained by extraction.

한편, 본 발명의 일실시예에 따른 피부미백용 화장료 조성물은, 홍화씨유 가수분해물 및 삼백초 추출물의 혼합물을 유효성분으로 함유하되, 상기 혼합물은 홍화씨유 가수분해물 및 삼백초 추출물을 2 : 0.5 내지 1.5 중량부 비로 혼합한 것일 수 있다. 한편, 상기 중량부 비 범위 내로 홍화씨유 가수분해물 및 삼백초 추출물을 혼합하는 경우, 홍화씨유 가수분해물의 티로시나아제(Tyrosinase) 단백질 레벨 억제 기전 및 삼백초 추출물의 MITF mRNA 발현 억제에 따른 MITF 단백질 생성 저해에 의한 티로시나아제(Tyrosinase) 생성 억제 기전의 상승 작용으로 인한 피부미백 효과를 최적화할 수 있다. On the other hand, the cosmetic composition for skin whitening according to an embodiment of the present invention contains a mixture of hydrolyzate safflower seed oil and extract of safflower seed oil as an active ingredient, wherein the mixture contains hydrolyzate of safflower oil and extract of safflower seed oil: 0.5 to 1.5 weight It may be mixed by booby ratio. On the other hand, when mixing the hydrolyzate of safflower seed oil and the extract of safflower seed oil within the weight part ratio range, the mechanism of inhibiting the tyrosinase protein level of the hydrolyzate of safflower oil and the inhibition of MITF protein production according to the inhibition of MITF mRNA expression of the extract It is possible to optimize the skin whitening effect due to the synergistic action of the tyrosinase production inhibitory mechanism.

또한, 본 발명의 일실시예에 따른 피부미백용 화장료 조성물에 있어서, 상기 혼합물은 조성물 전체 중량 기준, 0.001 내지 50 중량%로 포함되는 것일 수 있다. In addition, in the cosmetic composition for skin whitening according to an embodiment of the present invention, the mixture may be included in an amount of 0.001 to 50% by weight based on the total weight of the composition.

한편, 본 발명의 화장료 조성물에 포함되는 유효성분은 홍화씨유 가수분해물 및 삼백초 추출물의 혼합물 이외에, 화장품 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 일례로 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 함유제 등을 포함할 수 있다.On the other hand, the active ingredient contained in the cosmetic composition of the present invention may include ingredients commonly used in cosmetic compositions, in addition to a mixture of safflower seed oil hydrolyzate and safflower extract, for example, antioxidants, stabilizers, solubilizers, vitamins , and conventional containing agents such as pigments and fragrances.

또한, 본 발명의 홍화씨유 가수분해물 및 삼백초 추출물의 혼합물을 유효성분으로 함유하는 화장료 조성물은 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 일례로, 용액, 현탁액, 유탁액, 페이스트, 젤, 크림, 로션, 파우더, 비누, 계면활성제 함유 클린징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 1종 이상의 제형을 가질 수 있다.In addition, the cosmetic composition containing the mixture of the hydrolyzate of safflower seed oil and the extract of safflower seed oil of the present invention as an active ingredient can be prepared in any conventionally prepared formulation, for example, a solution, a suspension, an emulsion, a paste, a gel, It may have one or more formulations selected from the group consisting of cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, and spray.

실시예Example

이하, 본 발명의 내용을 하기 실시예 및 실험예를 통해 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예 및 실험예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다.Hereinafter, the contents of the present invention will be described in more detail through the following examples and experimental examples. However, the scope of the present invention is not limited only to the following examples and experimental examples, and includes modifications of technical ideas equivalent thereto.

제조예production example

홍화씨유 가수분해물(이하, SFH) 제조Manufacture of safflower seed oil hydrolyzate (hereinafter referred to as SFH)

500 ml 용량의 비이커에 홍화씨유 20g을 넣은 후 NaOH 20g을 정제수 36g에 용해한 수용액을 첨가하였다. 이 혼합용액을 90℃ 로 유지되는 항온수조에서 교반하면서 60분간 가수분해 반응을 진행시켰다. 가수분해 반응 도중 100g의 NaCl을 정제수 300g에 용해한 수용액을 냉장에서 냉각시킨 후 이 소금물 용액에 가수분해 반응이 종료된 용액을 서서히 첨가하였다. 생성된 고체를 감압여과한 후 다시 상온에서 감압건조하여 16.4g의 홍화씨유 가수분해물을 제조하였다. After putting 20 g of safflower seed oil in a 500 ml beaker, an aqueous solution in which 20 g of NaOH was dissolved in 36 g of purified water was added. The hydrolysis reaction was carried out for 60 minutes while stirring the mixed solution in a constant temperature water bath maintained at 90°C. During the hydrolysis reaction, an aqueous solution in which 100 g of NaCl was dissolved in 300 g of purified water was cooled in a refrigerator, and then the solution in which the hydrolysis reaction was completed was slowly added to the brine solution. The resulting solid was filtered under reduced pressure and dried again under reduced pressure at room temperature to prepare 16.4 g of a hydrolyzate of safflower seed oil.

삼백초 추출물(이하, SC) 제조Preparation of extract (hereinafter referred to as "SC")

삼백초(Saururus chinensis)를 준비하고, 에탄올 30% 수용액 및 에탄올 70% 수용액 각각을 이용하여 상온에서 일주일 간 추출하였다. 추출 종료 후 여과지를 이용하여 여과를 수행한 후 추출된 용액을 얻었으며, 감압농축 및 건조를 실시하여 목표로 하는 삼백초 추출물(에탄올 30% 수용액으로 수득(SC30) 4.52g, 에탄올 70% 수용액으로 수득(SC70) 3.95g)을 각각 획득하였다. Three hundred seconds ( Saururus chinensis ) was prepared, and extracted for a week at room temperature using each of an ethanol 30% aqueous solution and an ethanol 70% aqueous solution. After completion of the extraction, the extracted solution was obtained after filtration using a filter paper, and concentrated under reduced pressure and dried to obtain a target extract of Trichomaceae (obtained as a 30% aqueous solution of ethanol (SC30) 4.52 g, as a 70% aqueous solution of ethanol) (SC70) 3.95 g) were obtained, respectively.

실시예 1: 홍화씨유 가수분해물(SFH) 및 삼백초 추출물(SC) 혼합물 제조Example 1: Preparation of a mixture of safflower seed oil hydrolyzate (SFH) and trifolieae extract (SC)

상기 제조된 삼백초 추출물(SC30) 2.34g을 30%의 1,3-Butylene glycol 수용액 110g에 완전히 용해시킨 후, 여기에 상기 제조된 홍화씨유 가수분해물 4.68g을 첨가하여 50℃에서 교반하면서 용해시켰다. 1.0㎛ 멤브레인 필터와 0.45㎛ 멤브레인 필터를 순차적으로 이용하여 여과한 후 불용물 및 미생물이 완전히 제거된 홍화씨유 가수분해물 및 삼백초 추출물의 혼합물 100g을 제조하였다. After completely dissolving 2.34 g of the prepared trifolieae extract (SC30) in 110 g of a 30% aqueous 1,3-butylene glycol solution, 4.68 g of the prepared safflower seed oil hydrolyzate was added thereto and dissolved while stirring at 50°C. After filtration using a 1.0 μm membrane filter and a 0.45 μm membrane filter sequentially, 100 g of a mixture of safflower seed oil hydrolyzate and ginseng extract from which insoluble matter and microorganisms were completely removed was prepared.

[실험 1: 리놀레산 함량 측정][Experiment 1: Measurement of Linoleic Acid Content]

제조예에 따라 제조된 홍화씨유 가수분해물(SFH)에 함유된 리놀레산의 함량을 측정하기 위해, 아래 조건 하에서 분석을 진행하였으며, 표준물질은 supelco 37 component FAME Mix(purity 100%)를 사용하였다. 사용장비는 기체크로마토그래프(GC) Agilent 7890A를 사용하였으며, 분석조건 및 결과는 아래와 같았다. In order to measure the content of linoleic acid contained in the hydrolyzate of safflower seed oil (SFH) prepared according to Preparation Example, analysis was performed under the following conditions, and the standard material was supelco 37 component FAME Mix (purity 100%). The equipment used was a gas chromatograph (GC) Agilent 7890A, and the analysis conditions and results were as follows.

DetectorDetector FIDFID ColumnColumn SPTM-2560(100m x 0.25mm x 0.20μm)SPTM-2560 (100m x 0.25mm x 0.20μm) Injection Temp.Injection Temp. 225℃225℃ Injection VolumeInjection Volume 1.0μl1.0μl Detector Temp.Detector Temp. 285℃285℃ Oven Temp.Oven Temp. 100℃(4min.), 208℃(3℃/min, 5min), 244℃(2℃/min, 15min)100°C (4min.), 208°C (3°C/min, 5min), 244°C (2°C/min, 15min) Carrier GasCarrier Gas HeHe Column FlowColumn Flow 0.75mL/min.0.75 mL/min. Split RatioSplit Ratio 200:1200:1

시 료sample 홍화씨유safflower seed oil 홍화씨유 NaOH 가수분해물Safflower seed oil NaOH hydrolyzate 홍화씨유 Lipase가수분해물Safflower Seed Oil Lipase Hydrolyzate 리놀레인산 함량(%)Linoleic acid content (%) 1.31.3 59.8859.88 57.2457.24

표 2 및 도 1의 결과를 참조하면, 본 발명의 제조예에 따라 제조된 홍화씨유 가수분해물의 경우 리놀레산 함량이 약 59.88%로 나타났으며, 다른 오일류 대비 상당히 높은 함량의 값을 나타내는 것을 확인할 수 있었다. Referring to Table 2 and the results of FIG. 1, in the case of the hydrolyzate of safflower seed oil prepared according to the preparation example of the present invention, the linoleic acid content was about 59.88%, and it was confirmed that it exhibited a significantly higher value than other oils. there was.

[실험 2: 가속실험에 의한 안정성 테스트][Experiment 2: Stability test by accelerated experiment]

실시예 1에 따라 얻어진 홍화씨유 가수분해물(SFH) 및 삼백초 추출물(SC30)의 혼합물을 상온(25℃) 및 45℃의 인큐베이터에서 각각 0 개월, 1 개월, 2개월 간격으로 용액의 색과 pH 변화를 육안 및 pH 미터기로 측정한 결과 육안관찰에 의한 색변화는 관찰되지 않았으며 또한 시간에 따른 pH 변화도 거의 없는 것으로 측정되었다(도 2 참조). A mixture of safflower seed oil hydrolyzate (SFH) and trifolieae extract (SC30) obtained according to Example 1 in an incubator at room temperature (25 ° C) and 45 ° C. at 0 month, 1 month, and 2 month intervals, respectively. Changes in color and pH of the solution As a result of measuring with the naked eye and a pH meter, no color change was observed by visual observation, and it was also measured that there was almost no change in pH with time (see FIG. 2).

[실험 3: 세포생존율 측정 실험][Experiment 3: Cell viability measurement experiment]

세포 배양cell culture

Pam212 세포는 mouse keratinocyte, B16F0 세포는 mouse melanoma 세포주로 culture dish에 고착하여 증식한다. Pam212 세포 6 × 105 개, B16F0 세포 3 × 105 개를 100㎜ culture dish에 10 ㎖의 10% FBS를 포함하고 있는 DMEM 배지로 희석한 후 48시간 마다 계대배양하여 실험에 사용하였다. Pam212 cells are mouse keratinocytes, and B16F0 cells are mouse melanoma cell lines, which are adhered to the culture dish and proliferate. 6 × 10 5 Pam212 cells and 3 × 10 5 B16F0 cells were diluted with DMEM medium containing 10 ml of 10% FBS in a 100 mm culture dish and subcultured every 48 hours before use.

세포생존율 측정Cell viability measurement

MTT 방법은 흡광을 이용한 비색 측정법으로 세포의 생존능력을 측정하기 위해 사용하였다. Pam212 세포는 96-well culture plate에 5 × 103 cells/well로, B16F0세포는 96-well culture plate에 2.5 × 103 cells/well로 분주하고 24시간 뒤 96-well culture plate의 배지를 제거후 새로운 DMEM 10% FBS 배지와 계열 희석된 시료를 각각 처리하였다. 72시간 후 96-well culture plate의 배지를 제거하고 MTT 시약을 배지에 500 ug/ml 농도로 1시간 동안 반응시켰다. MTT 용액을 제거한 후 200 ul의 DMSO를 넣고 formazan 결정을 녹여 파장 590 nm에서 흡광도를 측정하였다.The MTT method was used to measure the viability of cells by a colorimetric method using absorbance. Pam212 cells at 5 × 10 3 cells/well in a 96-well culture plate and B16F0 cells at 2.5 × 10 3 cells/well in a 96-well culture plate. After 24 hours, remove the medium from the 96-well culture plate. Fresh DMEM 10% FBS medium and serially diluted samples were treated respectively. After 72 hours, the medium of the 96-well culture plate was removed and the MTT reagent was reacted with the medium at a concentration of 500 ug/ml for 1 hour. After removing the MTT solution, 200 ul of DMSO was added to dissolve the formazan crystal, and the absorbance was measured at a wavelength of 590 nm.

구체적으로, mouse melanoma인 B16F0 세포주와 mouse keratinocyte 세포주인 Pam212에 대한 각각의 시료의 세포 독성을 알아보기 위하여 살아있는 세포에서 미토콘드리아의 탈수소 효소작용에 의하여 노란색의 수용성 기질인 tetrazolium을 청자색을 띄는 비수용성의 formazan으로 환원시키는 기능을 이용한 MTT법을 이용하여 세포독성을 나타내지 않는 최대 농도를 확인하였다. B16F0 및 Pam212 cell에 대한 독성 유무를 확인하기 위해 각각의 시료를 72시간 세포를 배양 후 MTT 방법을 사용하여 세포 생존율을 측정하였다. 제조예에 따른 SC30, SC70 및 SFH를 각각의 농도별로 처리한후 MTT 세포 생존율을 B16F0 및 Pam212 cell에서 측정하였다. 그 결과 control 군의 생존율을 100 %로 놓았을 때 독성이 없는 농도를 처리할 수 있는 최대 농도로 확인하였다. 그 결과 도 3과 같이, SC30의 경우 100ug/ml, SC70의 경우 10ug/ml, SFH의 경우 100ug/ml을 최대 농도로 설정할 수 있음을 확인하였다.Specifically, in order to examine the cytotoxicity of each sample against the mouse melanoma B16F0 cell line and the mouse keratinocyte cell line Pam212, the yellow water-soluble substrate tetrazolium was converted to a blue-violet insoluble formazan by mitochondrial dehydrogenase action in living cells. The maximum concentration that does not exhibit cytotoxicity was confirmed by using the MTT method using the function of reducing to . In order to confirm the presence or absence of toxicity to B16F0 and Pam212 cells, each sample was incubated for 72 hours, and then cell viability was measured using the MTT method. After treatment with each concentration of SC30, SC70 and SFH according to Preparation Example, MTT cell viability was measured in B16F0 and Pam212 cells. As a result, when the survival rate of the control group was set to 100%, the concentration without toxicity was confirmed as the maximum concentration that can be treated. As a result, as shown in FIG. 3, it was confirmed that 100 ug/ml in the case of SC30, 10 ug/ml in the case of SC70, and 100 ug/ml in the case of SFH can be set as the maximum concentration.

[실험 4: 멜라닌양 측정 실험][Experiment 4: Melanin amount measurement experiment]

UVB 조사에 의한 melanin assay(Co-cullture system)melanin assay by UVB irradiation (Co-cullture system)

6-well plate에 B16F0 3.5 × 104 cells/well, 6-well plate insert에 Pam212 1 × 104 cells/well 세포를 24시간 키운 후, 배지를 제거하고 세포를 살짝 덮을 만큼의 PBS를 첨가하였다. UV-crosslinker를 이용하여 세포 생장률에 영향을 주지 않는 강도인 2 mJ/cm2로 조사하였다. PBS를 제거한 후 시료를 포함한 배지를 첨가 후 72시간 배양하고 405 nm 흡광도를 측정하여 멜라닌을 측정하였다. After growing B16F0 3.5 × 10 4 cells/well in a 6-well plate and Pam212 1 × 10 4 cells/well in a 6-well plate insert for 24 hours, the medium was removed and enough PBS was added to lightly cover the cells. Using a UV-crosslinker, it was irradiated with an intensity of 2 mJ/cm 2 that does not affect the cell growth rate. After removing the PBS, the medium containing the sample was added and cultured for 72 hours, and melanin was measured by measuring the absorbance at 405 nm.

구체적으로 Pam212 및 B16F0 co-culture 조건에서 UV 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 영향을 측정하기 위해, 피부와 유사한 조건의 keratinocyte 및 melanocytes co-culture 조건에서 UV를 자극하여 멜라닌 생합성을 유도한 후 SC30 및 SC70 추출물의 멜라닌 생합성에 대한 효과를 확인하였다. B16F0 과 Pam212 co-culture 조건에서 UV 2mJ/cm2로 자극한 후, 각각의 시료를 세포에 독성을 주지 않은 농도로 72 시간 동안 처리하고 흡광도 405 nm에서 세포에서 합성되어 배지로 방출된 melanin의 양을 측정하였다. 실험 결과 SC30 및 SC70은 멜라닌 생합성을 억제하였다(도 4 참조).Specifically, to measure the effect of the sample on the melanin biosynthesis generated by UV stimulation in Pam212 and B16F0 co-culture conditions, melanin biosynthesis was induced by UV stimulation in keratinocytes and melanocytes co-culture conditions similar to skin conditions. After SC30 and SC70 extract was confirmed the effect on melanin biosynthesis. After stimulation with UV 2mJ/cm 2 in B16F0 and Pam212 co-culture conditions, each sample was treated at a concentration that was not toxic to cells for 72 hours, and the amount of melanin synthesized and released into the medium at an absorbance of 405 nm was measured. As a result of the experiment, SC30 and SC70 inhibited melanin biosynthesis (see FIG. 4).

α-MSH 자극에 의한 melanin assaymelanin assay by α-MSH stimulation

96-well plate에 B16F0 2.5 × 103 cells/well로 분주 후 세포를 24시간 키운다. 100nM α-MSH와 시료를 포함한 배지를 첨가 후 72시간 배양하고 405 nm 흡광도를 측정하여 멜라닌 양을 계산하였다.After dispensing at 2.5 × 10 3 cells/well of B16F0 in a 96-well plate, the cells are grown for 24 hours. After adding the medium containing 100 nM α-MSH and the sample, it was cultured for 72 hours, and the amount of melanin was calculated by measuring the absorbance at 405 nm.

구체적으로, B16F0 세포주에서 α-MSH 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 영향을 측정하기 위해, B16F0 세포에 각각의 농도로 시료를 72 시간 동안 처리하고 흡광도 405 nm에서 세포에서 합성되어 배지로 방출된 melanin의 양을 측정하였다. 실험 결과 제조예에 따라 제조된 시료(SC30, SC70, SFH)의 경우는 α-MSH 자극에 의한 멜라닌 생합성을 억제하는 것을 확인하였다(도 5 참조).Specifically, in order to measure the effect of the sample on the biosynthesis of melanin produced by α-MSH stimulation in the B16F0 cell line, each concentration of the sample was treated in B16F0 cells for 72 hours, and the absorbance was synthesized in the cells at 405 nm and converted into a medium. The amount of released melanin was measured. As a result of the experiment, it was confirmed that the samples (SC30, SC70, SFH) prepared according to Preparation Example inhibit melanin biosynthesis by α-MSH stimulation (see FIG. 5 ).

위 실험 결과들을 분석하면, co-culture 시스템에서 UV에 의한 자극이나 B16F0에서 α-MSH에 의한 자극으로 멜라닌 생성이 증가하는데 제조예에 따른 SC30, SC70 및 SFH 가 이를 감소시켜주는 것을 확인할 수 있었다. Analyzing the above experimental results, it was confirmed that melanin production was increased by UV stimulation in the co-culture system or stimulation by α-MSH in B16F0, and SC30, SC70 and SFH according to the preparation example reduced it.

Pam212 및 B16F0 co-culture 조건에서 UV 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 ICSample IC for melanin biosynthesis produced by UV stimulation in Pam212 and B16F0 co-culture conditions 50 50 농도 측정concentration measurement

UV 자극에 의한 멜라닌 생성 억제 효과가 우수한 SC30, SC70, SFH를 선택하여 시료의 멜라닌 합성 저해율이 50%일 때의 시료 농도(IC50)를 확인하였다. B16F0 와 Pam212 co-culture 조건에서 UV 2 mJ/cm2로 자극한 후, 각각의 시료를 세포에 독성을 주지 않은 다양한 농도로 72 시간 동안 처리하고 흡광도 405 nm에서 세포에서 합성되어 배지로 방출된 melanin의 양을 측정하였다. 그 결과 UV 자극에 의한 멜라닌 50% 억제 농도(IC50)가 SC30의 경우 5.9 ug/ml, SC70의 경우 0.7ug/ml, SFH의 경우 22ug/ml로 확인되었다(도 6 참조).By selecting SC30, SC70, and SFH, which have excellent effect of inhibiting melanin production by UV stimulation, the sample concentration (IC 50 ) when the melanin synthesis inhibition rate of the sample was 50% was confirmed. After stimulation with UV 2 mJ/cm 2 in B16F0 and Pam212 co-culture conditions, each sample was treated with various concentrations that were not toxic to cells for 72 hours, and melanin synthesized in cells and released into the medium at absorbance 405 nm was measured. As a result, the 50% inhibition of melanin concentration (IC 50 ) by UV stimulation was confirmed to be 5.9 ug/ml for SC30, 0.7 ug/ml for SC70, and 22 ug/ml for SFH (see FIG. 6).

B16F0 세포주에서 α-MSH 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 ICSample IC for melanin biosynthesis produced by α-MSH stimulation in B16F0 cell line 50 50 농도density

α-MSH 자극에 의한 멜라닌 억제 효과가 우수한 SC30, SC70를 선택하여 시료의 멜라닌 합성 저해율이 50%일 때의 시료 농도 (IC50)를 확인하였다. B16F0 세포주에서 α-MSH로 자극하고 여러 농도의 시료를 72 시간 동안 처리하고 흡광도 405 nm에서 세포에서 합성되어 배지로 방출된 melanin의 양을 측정하였다. 그 결과 α-MSH 자극에 의한 멜라닌 50% 억제 농도인 IC50가 SC30의 경우 22 ug/ml, SC70의 경우 2ug/ml로 확인되었다(도 7 참조).By selecting SC30 and SC70 having excellent melanin inhibitory effect by α-MSH stimulation, the sample concentration (IC 50 ) when the melanin synthesis inhibition rate of the sample was 50% was confirmed. The B16F0 cell line was stimulated with α-MSH, samples of various concentrations were treated for 72 hours, and the amount of melanin synthesized and released into the medium at an absorbance of 405 nm was measured. As a result, it was confirmed that the IC 50 , which is the 50% inhibitory concentration of melanin by α-MSH stimulation, was 22 ug/ml in the case of SC30 and 2 ug/ml in the case of SC70 (see FIG. 7).

비교예 1-1, 1-2 및 1-3Comparative Examples 1-1, 1-2 and 1-3

실시예 1과 동일한 방식으로 혼합물을 제조하되, SFH와 SC70을 2 : 0.5 의 중량부 비로 혼합한 것(비교예 1-1), 2 : 0.1 의 중량부 비로 혼합한 것(비교예 1-2), SFH와 SC30을 2 : 0.5 의 중량부 비로 혼합한 것(비교예 1-3)만 달리하였다. A mixture was prepared in the same manner as in Example 1, except that SFH and SC70 were mixed in a ratio by weight of 2: 0.5 (Comparative Example 1-1), and mixed in a ratio by weight of 2: 0.1 (Comparative Example 1-2) ), SFH and SC30 were mixed in a weight part ratio of 2: 0.5 (Comparative Example 1-3).

[실험 5: 세포생존율 측정 실험][Experiment 5: Cell viability measurement experiment]

세포생존율 측정Cell viability measurement

MTT 방법은 흡광을 이용한 비색 측정법으로 세포의 생존능력을 측정하기 위해 사용하였다. Pam212 세포는 96-well culture plate에 5 × 103 cells/well로, B16F0세포는 96-well culture plate에 2.5 × 103 cells/well로 분주하고 24시간 뒤 96-well culture plate의 배지를 제거 후 새로운 DMEM 10% FBS 배지와 계열 희석된 시료를 각각 처리하였다. 72시간후 96-well culture plate의 배지를 제거하고 MTT 시약을 배지에 500 ug/ml 농도로 1시간 동안 반응시켰다. MTT 용액을 제거한 후 200 ul의 DMSO를 넣고 formazan 결정을 녹여 파장 590 nm에서 흡광도를 측정하였다.The MTT method was used to measure the viability of cells by a colorimetric method using absorbance. After dispensing Pam212 cells at 5 × 10 3 cells/well in a 96-well culture plate and B16F0 cells at 2.5 × 10 3 cells/well in a 96-well culture plate, remove the medium from the 96-well culture plate after 24 hours. Fresh DMEM 10% FBS medium and serially diluted samples were treated respectively. After 72 hours, the medium from the 96-well culture plate was removed, and MTT reagent was reacted with the medium at a concentration of 500 ug/ml for 1 hour. After removing the MTT solution, 200 ul of DMSO was added to dissolve the formazan crystal, and the absorbance was measured at a wavelength of 590 nm.

구체적으로, mouse melanoma인 B16F0 세포주와 mouse keratinocyte 세포주인 Pam212에 대한 각각의 시료의 세포 독성을 알아보기 위하여 살아있는 세포에서 미토콘드리아의 탈수소 효소작용에 의하여 노란색의 수용성 기질인 tetrazolium을 청자색을 띄는 비수용성의 formazan으로 환원시키는 기능을 이용한 MTT법을 이용하여 세포독성을 나타내지 않는 최고농도를 확인하였다. B16F0 및 Pam212 cell에 대한 독성 유무를 확인하기 위해 각각의 시료를 72시간 세포를 배양 후 MTT 방법을 사용하여 세포 생존율을 측정하였다. 실시예 1, 비교예 1-1 내지 1-3의 혼합물을 72시간 세포 배양 후 MTT 방법을 사용하여 세포 생존율을 측정하였으며, 그 결과 control 군의 생존율을 100%로 놓았을 때, 독성이 없이 처리할 수 있는 최대 농도를 확인하였다(도 8 참조).Specifically, in order to examine the cytotoxicity of each sample against the mouse melanoma B16F0 cell line and the mouse keratinocyte cell line Pam212, the yellow water-soluble substrate tetrazolium was converted to a blue-violet insoluble formazan by mitochondrial dehydrogenase action in living cells. The highest concentration that does not show cytotoxicity was confirmed using the MTT method using the function of reducing In order to confirm the presence or absence of toxicity to B16F0 and Pam212 cells, each sample was incubated for 72 hours, and then cell viability was measured using the MTT method. Cell viability was measured using the MTT method after 72 hours of cell culture in the mixture of Example 1 and Comparative Examples 1-1 to 1-3, and as a result, when the viability of the control group was set to 100%, treatment without toxicity The maximum concentration possible was confirmed (see FIG. 8).

[실험 6: 멜라닌 생합성에 주는 영향 측정 실험][Experiment 6: Measurement of the effect on melanin biosynthesis]

실시예 및 비교예 혼합물의 Pam212 및 B16F0 co-culture 조건에서 UV 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 영향 Effects of samples on melanin biosynthesis produced by UV stimulation in Pam212 and B16F0 co-culture conditions of the mixtures of Examples and Comparative Examples

실시예 1, 비교예 1-1 내지 1-3의 혼합물을 기초로, B16F0 과 Pam212 co-culture 조건에서 UV 2 mJ/cm2로 자극한 후, 혼합물에 의한 melanin 합성 억제 효과를 확인하였다. 그 결과 UV 자극에 의한 멜라닌 50% 억제 농도인 IC50가 SFH와 SC70 비율 2 : 0.5 인 혼합물(비교예 1-1)의 경우 SFH 5ug/ml, SC70 1.3 ug/ml을 보였고, 비율 2 : 0.1 인 혼합물(비교예 1-2)의 경우 SFH 11.7 ug/ml, SC70 0.6 ug/ml을 나타냈다. SFH와 SC30 비율 2 : 1 인 혼합물(실시예 1)의 경우 IC50가 SFH 6.5 ug/ml, SC70 0.6 ug/ml을 보이고, 비율 2 : 0.5 인 혼합물(비교예 1-3)의 경우 IC50가 SFH 12.3 ug/ml, SC70 3.1 ug/ml을 나타냈다(도 9 참조). Based on the mixture of Example 1 and Comparative Examples 1-1 to 1-3, after stimulation with UV 2 mJ/cm 2 in B16F0 and Pam212 co-culture conditions, the effect of inhibiting melanin synthesis by the mixture was confirmed. As a result, the IC 50 , which is the 50% inhibitory concentration of melanin by UV stimulation, showed SFH 5ug/ml, SC70 1.3 ug/ml, and ratio 2: 0.1 in the case of a mixture (Comparative Example 1-1) of SFH and SC70 ratio of 2: 0.1 In the case of a phosphorus mixture (Comparative Example 1-2), 11.7 ug/ml of SFH and 0.6 ug/ml of SC70 were shown. In the case of a mixture (Example 1) having a SFH and SC30 ratio of 2: 1, IC 50 is SFH 6.5 ug/ml, SC70 0.6 ug/ml, and in the case of a mixture (Comparative Example 1-3) having a ratio of 2: 0.5, IC 50 showed SFH 12.3 ug/ml and SC70 3.1 ug/ml (see FIG. 9).

실시예 및 비교예 혼합물의 B16F0 세포주에서 α-MSH 자극에 의해서 생성되는 멜라닌 생합성에 대한 시료의 영향 Effect of sample on melanin biosynthesis produced by α-MSH stimulation in B16F0 cell line of the mixture of Examples and Comparative Examples

실시예 1, 비교예 1-1 내지 1-3의 혼합물을 기초로 B16F0 세포주에서 α-MSH에 생성되는 melanin 생합성에 어떤 영향을 주는지 확인하였다. B16F0 세포에 각각의 농도로 시료를 72 시간 동안 처리하고 흡광도 405 nm에서 세포에서 합성되어 배지로 방출된 melanin의 양을 측정하였다. 실험 결과 α-MSH 자극에 의한 멜라닌 50% 억제 농도인 IC50가 비교예 1-1의 혼합물의 경우 SFH 5.9 ug/ml, SC70 1.5 ug/ml을 보였고, 비교예 1-2의 혼합물의 경우 SFH 19.3 ug/ml, SC70 1 ug/ml을 나타냈다. 실시예 1의 혼합물의 경우 IC50가 SFH 18.5 ug/ml, SC70 9.3 ug/ml을 보였고, 비교예 1-3의 혼합물의 경우 IC50가 SFH 19.6 ug/ml, SC70 4.9 ug/ml을 나타냈다(도 10 참조). Based on the mixture of Example 1 and Comparative Examples 1-1 to 1-3, it was confirmed how it affects melanin biosynthesis produced in α-MSH in the B16F0 cell line. Samples were treated at each concentration in B16F0 cells for 72 hours, and the amount of melanin synthesized in the cells and released into the medium at an absorbance of 405 nm was measured. As a result of the experiment, the IC 50 , which is the 50% inhibitory concentration of melanin by α-MSH stimulation, showed 5.9 ug/ml of SFH and 1.5 ug/ml of SC70 in the case of the mixture of Comparative Example 1-1, and SFH in the case of the mixture of Comparative Example 1-2. 19.3 ug/ml, and 1 ug/ml SC70. For the mixture of Example 1, IC 50 SFH 18.5 ug/ml, SC70 9.3 ug/ml, and for the mixture of Comparative Example 1-3, IC 50 SFH 19.6 ug/ml, SC70 4.9 ug/ml ( see Fig. 10).

위 실험 결과들을 참조하면, SFH, SC70, SC30을 각각 단독 사용하는 경우 대비 SFH와 SC70의 조합 및 SFH와 SC30의 조합에 의한 혼합물로 사용 시 멜라닌 IC50 값이 더 낮아다는 점을 확인할 수 있으며, 이에 따라 단일제보다 SC70/SFH 또는 SC30/SFH 혼합물이 더욱 우수한 미백 효과를 나타낸다는 점을 확인할 수 있다. Referring to the above experimental results, it can be confirmed that the melanin IC 50 value is lower when using a mixture by a combination of SFH and SC70 and a combination of SFH and SC30 compared to when SFH, SC70, and SC30 are used alone, Accordingly, it can be confirmed that the SC70/SFH or SC30/SFH mixture exhibits a better whitening effect than the single agent.

특히, 실시예 1에 따른 혼합물과 같이 SFH가 30 ug/ml, SC30이 15ug/ml 농도로 포함(2 : 1의 중량부 비로 혼합)된 혼합물의 경우, 세포 독성을 나타내지 않는 범위 내에서, UV 또는 α-MSH 자극에 의한 멜라닌 생성을 90% 이상 억제할 수 있다는 점을 확인할 수 있었다(아래 표 3 참조).In particular, in the case of a mixture containing SFH at a concentration of 30 ug/ml and SC30 at a concentration of 15 ug/ml (mixed in a ratio by weight of 2: 1), as in the mixture according to Example 1, within a range that does not exhibit cytotoxicity, UV Alternatively, it could be confirmed that melanin production by α-MSH stimulation could be inhibited by more than 90% (see Table 3 below).

Figure pat00001
Figure pat00001

[실험 7: 웨스턴 블롯][Experiment 7: Western Blot]

멜라닌 합성 마커 MITF-M의 단백질 레벨 확인Confirmation of protein level of melanin synthesis marker MITF-M

실시예 1에 따른 혼합물의 멜라닌 합성 마커 MITF-M의 단백질 레벨을 확인하기 위해, 웨스턴 블롯을 통해 정량 분석을 수행하였다. SFH 단독 처리의 경우 α-MSH 자극에 의해 증가된 MITF-M 단백질양을 억제하지 못하였으나, SC30 단독 처리 또는 실시예 1의 혼합물 처리시에는 MITF-M 단백질 양을 억제하는 것을 확인할 수 있었다(도 11 참조). To confirm the protein level of the melanin synthesis marker MITF-M of the mixture according to Example 1, quantitative analysis was performed through Western blot. In the case of SFH alone treatment, the amount of MITF-M protein increased by α-MSH stimulation could not be suppressed, but it was confirmed that the amount of MITF-M protein was suppressed when SC30 alone or the mixture of Example 1 was treated (Fig. 11).

멜라닌 합성 마커 Tyrosinase의 mRNA 및 단백질 레벨 확인Confirmation of mRNA and protein levels of the melanin synthesis marker Tyrosinase

실시예 1의 혼합물이 멜라닌 생합성에 가장 중요한 단백질인 Tyrosinase의 mRNA 및 단백질 레벨에 영향을 주고 있는지 RT-PCR과 웨스턴블롯을 통해 정량분석하였다. 그 결과 SFH 단독 처리할 경우 αMSH 자극에 의해 증가된 Tyrosinase 단백질양을 억제하고, mRNA 레벨은 억제하지 못했다. 그러나 SC30 단독제제 및 실시예 1의 혼합물은 모두 Tyrosinase mRNA 및 단백질양을 모두 억제하였다. 이 결과는 SFH 단독제재는 Tyrosinase 단백질 억제에 관여하고, SC30은 MITF mRNA 발현 억제에 따른 MITF-M 단백질 생성 저해 및 이로 인한 Tyrosinase 생성 억제에 의해 멜라닌 합성을 억제하고 있음을 나타낸다. 특히, 실시예 1의 혼합물의 경우 티로시나아제(Tyrosinase) 단백질 레벨을 직접적으로 억제하는 기전 및 MITF mRNA 발현 억제에 따른 MITF 단백질 생성 저해에 의한 티로시나아제(Tyrosinase) 생성 억제 기전 등 2가지 기전의 복합적인 작용에 의한 상승 효과로서 뛰어난 피부미백 효과를 나타낸다(도 12 참조).Whether the mixture of Example 1 affects mRNA and protein levels of Tyrosinase, the most important protein for melanin biosynthesis, was quantitatively analyzed through RT-PCR and Western blot. As a result, when SFH alone was treated, the amount of tyrosinase protein increased by αMSH stimulation was suppressed, but the mRNA level was not suppressed. However, SC30 alone and the mixture of Example 1 both inhibited both Tyrosinase mRNA and protein levels. These results indicate that SFH alone is involved in tyrosinase protein inhibition, and SC30 inhibits melanin synthesis by inhibiting MITF-M protein production by inhibiting MITF mRNA expression and by inhibiting tyrosinase production. In particular, in the case of the mixture of Example 1, two mechanisms such as a mechanism for directly inhibiting the tyrosinase protein level and a mechanism for inhibiting the production of tyrosinase by inhibition of MITF protein production according to the inhibition of MITF mRNA expression It shows an excellent skin whitening effect as a synergistic effect by a complex action (see Fig. 12).

정리하면, 위의 실험을 통해 확인할 수 있는 바와 같이, UV가 표피의 keratinocyte를 자극하면, keratinocyte는 melanin 합성 신호 전달 체계를 자극할 수 있는 paracrine factor인 α-MSH, ET-1, SCF를 분비한다. 이 단백질들은 melanocyte에 있는 각각의 수용체에 결합하여 MITF mRNA 발현을 증가시키고 이로 인해 증가된 MITF-M은 Tyrosinase 생성의 프로모터(promotor)에 결합하여 Tyrosinase 단백질 생성을 증가시킴으로써, 피부 멜라닌 합성을 촉진시킨다. 한편, SFH 단독 적용시에는 Tyrosinase 단백질 레벨을 직접 억제하고, SC30 단독 적용시에는 MITF-M 단백질과 Tyrosinase mRNA를 모두 억제시킨다. 결국, 실시예 1의 혼합물은 두 제재의 복합적인 효과로 인하여, Tyrosinase 단백질 레벨을 억제시키고, Tyrosinase의 mRNA 및 Tyrosinase 생성의 중요 전사인자인 MITF-M 단백질양을 모두 억제함으로써, 멜라닌 합성을 저해하여 우수한 미백 효과를 나타낸다는 점을 확인할 수 있다(도 13 참조).In summary, as can be seen from the above experiment, when UV stimulates epidermal keratinocytes, keratinocytes secrete α-MSH, ET-1, and SCF, which are paracrine factors that can stimulate the melanin synthesis signaling system. . These proteins bind to respective receptors in melanocytes to increase MITF mRNA expression, and the increased MITF-M binds to a promoter of tyrosinase production and increases tyrosinase protein production, thereby promoting skin melanin synthesis. On the other hand, when SFH is applied alone, it directly inhibits the tyrosinase protein level, and when SC30 is applied alone, both MITF-M protein and Tyrosinase mRNA are inhibited. After all, the mixture of Example 1 suppresses the Tyrosinase protein level due to the combined effect of the two agents, and inhibits melanin synthesis by inhibiting both the mRNA of Tyrosinase and the amount of MITF-M protein, which is an important transcription factor for Tyrosinase production. It can be seen that an excellent whitening effect is exhibited (see FIG. 13).

[실험 8: 피부밝기 개선효과 임상시험][Experiment 8: Clinical trial for skin brightness improvement effect]

12명의 건강한 성인 여성(평균연령 51.25)을 대상으로, 상기 실시예 1의 혼합물이 포함된 크림 제형을 얼굴 부위에 적용하고, 적용 2주 후 및 적용 4주 후 각각 과색소침착 부위의 피부밝기(L*) 및 L* 값에 대한 개인 증가율(%)의 평균을 각각 측정하여 아래 표 4 및 표 5에서 나타내었다. For 12 healthy adult women (average age 51.25), the cream formulation containing the mixture of Example 1 was applied to the face area, and the skin brightness ( L*) and the average of the individual increase rate (%) for the L* value were respectively measured and shown in Tables 4 and 5 below.

적용 2주 후 2 weeks after application 적용 4주 후4 weeks after application L*값의 개인증가율(%)Personal increase rate of L* value (%) 0.0990.099 0.2950.295

표 4의 결과를 살펴보면, L* 값은 제품 적용 전에 비하여 적용 2주 후 및 적용 4주 후 각각 0.099%, 0.285%의 증가율을 나타내었다. 한편, L* 값이 증가된 연구 대상자의 비율을 분석한 결과 적용 2주 후, 적용 4주 후, 각각 75.000%, 100.000%의 연구 대상자가 L* 값의 증가를 나타낸 것을 확인할 수 있었다(아래 표 5 참조).Looking at the results in Table 4, the L* value showed an increase rate of 0.099% and 0.285%, respectively, after 2 weeks and 4 weeks after application compared to before product application. On the other hand, as a result of analyzing the proportion of study subjects with increased L* value, it was confirmed that 75.000% and 100.000% of study subjects showed an increase in L* value after 2 weeks of application and 4 weeks after application (Table below) 5).

적용 2주 후 2 weeks after application 적용 4주 후4 weeks after application L*값이 증가된 연구대상자 비율(%)Proportion of study subjects with increased L* value (%) 75.00075.000 100.000100.000

이상으로 설명한 바와 같이, 본원 발명에 따라 홍화씨유 가수분해물(SFH) 및 삼백초 추출물(SC30)을 특정 중량부 비로 함유하는 혼합물(SS-Complex)의 경우 Tyrosinase 단백질 레벨을 억제하는 기전 및 MITF 단백질 생성과 Tyrosinase mRNA를 억제하는 기전을 동시에 수행할 수 있어, 두 가지 경로로 멜라닌 생성을 효과적으로 억제하며, 이에 의해 피부미백과 관련된 강한 상승 효과를 나타낼 수 있다는 점을 확인할 수 있었다. As described above, in the case of a mixture (SS-Complex) containing safflower seed oil hydrolyzate (SFH) and trifolieae extract (SC30) in a specific weight part ratio according to the present invention, the mechanism of inhibiting the tyrosinase protein level and MITF protein production and It can be confirmed that the mechanism of inhibiting tyrosinase mRNA can be simultaneously performed, effectively inhibiting melanin production by two pathways, thereby exhibiting a strong synergistic effect related to skin whitening.

앞에서, 본 발명의 특정한 실시예가 설명되고 도시되었지만 본 발명은 기재된 실시예에 한정되는 것이 아니고, 본 발명의 사상 및 범위를 벗어나지 않고 다양하게 수정 및 변형할 수 있음은 이 기술의 분야에서 통상의 지식을 가진 자에게 자명한 일이다. 따라서, 그러한 수정예 또는 변형예들은 본 발명의 기술적 사상이나 관점으로부터 개별적으로 이해되어서는 안되며, 변형된 실시예들은 본 발명의 특허청구범위에 속한다 하여야 할 것이다.In the foregoing, specific embodiments of the present invention have been described and illustrated, but it is common knowledge in the art that the present invention is not limited to the described embodiments, and that various modifications and variations can be made without departing from the spirit and scope of the present invention. It is self-evident to those who have Accordingly, such modifications or variations should not be individually understood from the technical spirit or point of view of the present invention, and modified embodiments should be said to belong to the claims of the present invention.

Claims (6)

홍화씨유 가수분해물 및 삼백초 추출물의 혼합물을 유효성분으로 함유하는, 피부미백용 화장료 조성물. A cosmetic composition for skin whitening, comprising a mixture of safflower seed oil hydrolyzate and safflower extract as an active ingredient. 제 1 항에 있어서,
상기 혼합물은 홍화씨유 가수분해물 및 삼백초 추출물을 2 : 0.5 내지 1.5 중량부 비로 혼합한 것인, 피부미백용 화장료 조성물.
The method of claim 1,
The mixture is a mixture of safflower seed oil hydrolyzate and safflower seed extract in a ratio of 2: 0.5 to 1.5 parts by weight, a cosmetic composition for skin whitening.
제 1 항에 있어서,
상기 홍화씨유 가수분해물은 홍화씨유에 수산화나트륨(NaOH), 수산화칼슘(Ca(OH)2), 수산화리튬(LiOH) 및 수산화칼륨(KOH)으로 이루어진 군에서 선택되는 1종 이상의 알칼리금속 수산화물을 처리하여 가수분해시킨 것 또는,
홍화씨유에 에스테르 가수분해 효소를 첨가하여 가수분해시킨 것인, 피부미백용 화장료 조성물.
The method of claim 1,
The safflower seed oil hydrolyzate is hydrolyzed by treating safflower seed oil with at least one alkali metal hydroxide selected from the group consisting of sodium hydroxide (NaOH), calcium hydroxide (Ca(OH) 2 ), lithium hydroxide (LiOH) and potassium hydroxide (KOH). decomposed or
A cosmetic composition for skin whitening, which is hydrolyzed by adding an ester hydrolytic enzyme to safflower seed oil.
제 1 항에 있어서,
상기 삼백초 추출물은 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 부틸렌글리콜, 프로필렌글리콜, 함수부틸렌글리콜, 함수프로필렌글리콜 및 함수글리세린으로 이루어지는 군에서 선택되는 1종 이상의 용매로 추출된, 피부미백용 화장료 조성물.
The method of claim 1,
The trifolium extract is water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, butylene glycol, propylene glycol, water-containing butylene glycol, water-containing propylene glycol, and water-containing one or more solvents selected from the group consisting of glycerin. Extracted, cosmetic composition for skin whitening.
제 1 항에 있어서,
상기 혼합물은 조성물 전체 중량 기준, 0.001 내지 50 중량%로 포함되는 것인, 피부미백용 화장료 조성물.
The method of claim 1,
The mixture is included in an amount of 0.001 to 50% by weight based on the total weight of the composition, a cosmetic composition for skin whitening.
제 1 항에 있어서,
상기 조성물은 용액, 현탁액, 유탁액, 페이스트, 젤, 크림, 로션, 파우더, 비누, 계면활성제 함유 클린징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군으로부터 선택되는 1종 이상의 제형을 가지는, 피부미백용 화장료 조성물.
The method of claim 1,
The composition is one or more formulations selected from the group consisting of solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing, oils, powder foundations, emulsion foundations, wax foundations, and sprays. Having, a cosmetic composition for skin whitening.
KR1020210001283A 2021-01-06 2021-01-06 Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract Active KR102522196B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210001283A KR102522196B1 (en) 2021-01-06 2021-01-06 Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210001283A KR102522196B1 (en) 2021-01-06 2021-01-06 Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract

Publications (2)

Publication Number Publication Date
KR20220099259A true KR20220099259A (en) 2022-07-13
KR102522196B1 KR102522196B1 (en) 2023-04-19

Family

ID=82401229

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210001283A Active KR102522196B1 (en) 2021-01-06 2021-01-06 Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract

Country Status (1)

Country Link
KR (1) KR102522196B1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020035656A (en) * 2000-05-31 2002-05-15 이세복 Inhibition agent of tyrosinase composed of saururus chinensis(lour) baill extract and cosmetic composition having whitening effect containing the same
KR20080101821A (en) * 2008-08-27 2008-11-21 김선일 Skin external composition comprising safflower fraction
JP2014001391A (en) * 2001-07-02 2014-01-09 Aldivia Sa Lanolin substitute, and production method and applications thereof
CN106635429A (en) * 2016-11-16 2017-05-10 武汉谷羽堂生物科技有限公司 Process for enriching unsaturated fatty acid from safflower seed oil via enzymatic hydrolysis
KR20180048408A (en) * 2016-10-31 2018-05-10 주식회사 코씨드바이오팜 Whitening cosmetics containing the Saururus chinensis (Lour.) Baill. with improved whitening activity by Jeju Shindari fermentation method and producing method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020035656A (en) * 2000-05-31 2002-05-15 이세복 Inhibition agent of tyrosinase composed of saururus chinensis(lour) baill extract and cosmetic composition having whitening effect containing the same
JP2014001391A (en) * 2001-07-02 2014-01-09 Aldivia Sa Lanolin substitute, and production method and applications thereof
KR20080101821A (en) * 2008-08-27 2008-11-21 김선일 Skin external composition comprising safflower fraction
KR20180048408A (en) * 2016-10-31 2018-05-10 주식회사 코씨드바이오팜 Whitening cosmetics containing the Saururus chinensis (Lour.) Baill. with improved whitening activity by Jeju Shindari fermentation method and producing method thereof
CN106635429A (en) * 2016-11-16 2017-05-10 武汉谷羽堂生物科技有限公司 Process for enriching unsaturated fatty acid from safflower seed oil via enzymatic hydrolysis

Also Published As

Publication number Publication date
KR102522196B1 (en) 2023-04-19

Similar Documents

Publication Publication Date Title
KR20110054022A (en) Whitening and anti-aging agents, and skin cosmetics
US20110117038A1 (en) Dopa Oxidase Inhibitor, Skin-Lightening Agent and External Preparation for Skin
KR101824770B1 (en) Anti-wrinkle cosmetic composition comprising essentially Polygonum multiflorum adventitious extract
MX2013008133A (en) Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents.
KR100521768B1 (en) Cosmetic Compositions for a Skin Whitening
KR20110018091A (en) Skin Whitening Composition
CN106413687B (en) Product and its preparation method and application containing gadol extract and ginkgo biloba extract
KR20020035656A (en) Inhibition agent of tyrosinase composed of saururus chinensis(lour) baill extract and cosmetic composition having whitening effect containing the same
KR100920896B1 (en) Cosmetic composition for skin whitening containing blue lotus and tetrahydrocurcumin as an active ingredient
KR100967018B1 (en) Skin whitening cosmetics containing plant extracts
KR101854766B1 (en) Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts
KR101430636B1 (en) Functional cosmetic composition comprising ginsenosides Rh2 and Rg3
EP2772255B1 (en) Composition comprising syringaresinol for improving the skin
KR102522196B1 (en) Skin whitening composition comprising Safflower seed oil hydrolyzate and Saururus chinensis extract
JPH0987164A (en) Skin preparation for external use
KR100829819B1 (en) Cosmetic composition for skin whitening containing panduratin derivative
KR101686521B1 (en) Composition for beauty of skin
KR20160081445A (en) A composition for antioxidating, whitening and improving wrinkle comprising extracts of false indigo
KR102168533B1 (en) Cosmetic composition for whitening or improving the facial color containing herb extracts
KR101317433B1 (en) The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage
KR20020084429A (en) Cosmetic composition containing a Rosa davurica Pall extracts for application to the skin
KR20170013588A (en) Composition for skin whitening and anti-wrinkle comprising Cistanche deserticola extract as effective component
KR20030085771A (en) A composition for whitening containing dropwort extract
JPH0987135A (en) Dermal preparation for external use
KR100744947B1 (en) Cosmetic composition for skin whitening containing cheongung extract and protease as active ingredients

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20210106

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220825

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230410

PG1601 Publication of registration